Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 3Thoracic 1Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1Gynecologic 1Genitourinary 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 750Leukemia, Myeloid, Acute 635Leukemia 476Leukemia, Myelogenous, Chronic, BCR-ABL Positive 470Precursor Cell Lymphoblastic Leukemia-Lymphoma 409Myeloproliferative Disorders 339Lymphoma, Non-Hodgkin 271Leukemia, Myelomonocytic, Chronic 270Leukemia, Lymphocytic, Chronic, B-Cell 264Multiple Myeloma 259Hodgkin Disease 249Primary Myelofibrosis 230Leukemia, Myeloid, Chronic-Phase 217Lymphoma 203Blast Crisis 195Leukemia, Myeloid, Accelerated Phase 182Lymphoma, Mantle-Cell 168Lymphoma, Follicular 168Burkitt Lymphoma 166Lymphoma, Large B-Cell, Diffuse 162Lymphoma, B-Cell, Marginal Zone 151Congenital Abnormalities 148Polycythemia Vera 144Lymphoma, Large-Cell, Immunoblastic 141Anemia, Refractory, with Excess of Blasts 131Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 128Myelodysplastic-Myeloproliferative Diseases 126Neoplasms, Plasma Cell 117Thrombocythemia, Essential 114Lymphoma, T-Cell, Cutaneous 99

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Treatment Adherence and Compliance × Myeloid × Clear all
NCT05260203 2024-11-06

MargheRITA

Advice Pharma Group srl

Phase NA Completed
124 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Treatment Adherence and Compliance, Amyloidosis, Anemia, Refractory, with Excess of Blasts, Hodgkin Disease, Multiple Myeloma, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, B-Cell, Lymphoma, T-Cell, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡